Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Failure of bamlanivimab with selection of E484K mutation in an allogeneic stem cell transplant recipient with nosocomial SARS-CoV-2 infection.

Inès Boussen,Maud Salmona,Flore Sicre De Fontbrune,Aliénor Xhaard,Nathalie De Castro,Constance Delaugerre,Marie-Laure Chaix,Jean-Michel Molina

Antiviral therapy（2024）

Cited 0|Views15
No score
Abstract
We report the case of an allogeneic stem cell transplant recipient with nosocomial acquisition of SARS-CoV-2 infection who received antispike neutralizing monoclonal antibody bamlanivimab 2 days after diagnosis of SARS-CoV-2 infection but progressed to severe COVID-19 pneumonia and died with the selection of E484K/Q resistance mutations to bamlanivimab.
More
Translated text
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined